TCG
ELV icon

Transcendent Capital Group’s Elevance Health ELV Stock Holding History

Transcendent Capital Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40
Closed -$14.8K – 179
2024
Q4 		$14.8K Hold
40
– – 0.01% 305
2024
Q3 		$20.8K Hold
40
– – 0.01% 289
2024
Q2 		$21.7K Hold
40
– – 0.01% 259
2024
Q1 		$20.7K Hold
40
– – 0.01% 258
2023
Q4 		$18.9K Buy
+40
New +$18.5K 0.01% 220

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Transcendent Capital Group's ELV Position: Q1 2025 in Review

Transcendent Capital Group sold out of Elevance Health (ELV) in Q1 2025, closing a stake of 40 shares — an estimated $14.8K sold.

Transcendent Capital Group first reported a position in ELV in Q4 2023 and held it in 5 quarters. The position peaked at $21.7K in Q2 2024. 1,660 funds tracked by Wall St. Rank hold ELV as of Q1 2025.

  • Transcendent Capital Group reported no remaining Elevance Health position as of Q1 2025 after selling out during the quarter.
  • Transcendent Capital Group sold 40 Elevance Health shares in Q1 2025, an estimated $14.8K.
  • Transcendent Capital Group first reported a position in Elevance Health in Q4 2023 and held it in 5 quarters.
  • Transcendent Capital Group's Elevance Health position peaked at $21.7K in Q2 2024.
  • 1,660 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.

Based on Transcendent Capital Group's 13F filing for Q1 2025, filed 2 May 2025.